Viewing Study NCT05627466


Ignite Creation Date: 2025-12-24 @ 4:03 PM
Ignite Modification Date: 2025-12-31 @ 6:21 PM
Study NCT ID: NCT05627466
Status: NO_LONGER_AVAILABLE
Last Update Posted: 2024-02-15
First Post: 2022-11-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: US Expanded Access Program for Magrolimab in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Sponsor: Gilead Sciences
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module